Results 51 to 60 of about 850,055 (258)
ABSTRACT We aimed to compare the long‐term efficacy and safety of drug‐coated balloon (DCB) and drug‐eluting stent (DES) following atherectomy for coronary arteries with severely calcified lesions. Of the 258 consecutive patients and 422 de novo lesions treated with DCB at Kanazawa Medical University Hospital, we retrospectively enrolled highly ...
Taka‐aki Takamura+11 more
wiley +1 more source
Restenosis after coronary angioplasty: An overview
Despite substantial basic and clinical efforts to address the problem of restenosis after percutaneous coronary intervention, effective preventive therapies have not yet been developed. Nevertheless, the accumulated information has provided much insight into the process of restenosis in addition to allowing standards to be developed for adequate ...
Robert M. Califf+9 more
openaire +2 more sources
Does lipoprotein (a) level have a predictive value in restenosis after coronary stenting?
Objectives: Lipid disorders, lipoproteins, diabetes mellitus, and hypertension are the known risk factors for coronary artery diseases; however, their role is unknown in restenosis after coronary stenting.
Alireza Khosravi+5 more
doaj
Aim. The marked variation in bifurcation anatomy has brought about an ongoing search for stents specifically constructed for coronary bifurcations.
Robert J. Gil+7 more
doaj +1 more source
ABSTRACT Chronic mesenteric ischemia (CMI) secondary to extensive paravisceral atherosclerosis is a rare but challenging vascular condition, often presenting with postprandial abdominal pain, weight loss, and claudication due to impaired blood flow. While surgical bypass is a standard treatment, it carries significant risks, particularly in patients ...
Dipankar Mukherjee+2 more
wiley +1 more source
Repeat coronary angioplasty as treatment for restenosis
Repeat coronary angioplasty has become the standard approach to a first restenosis. However, the long-term outcome of such a strategy is not well defined. In the present study, 465 patients (mean age 58 years [range 27 to 79], 53% with multivessel disease) underwent a second angioplasty procedure at the same site.
Irving Franco+7 more
openaire +3 more sources
ABSTRACT Background and Aims Clinical trial research on the safety and efficacy of coronary orbital atherectomy (OA) in diabetics compared to non‐diabetics is limited. This single‐center study aimed to perform a diabetic comparative analysis using real‐world data.
Benjamin Klein+9 more
wiley +1 more source
In the last 10 years the World has increased significantly the frequency of joint replacement in patients with coronary artery disease. Coronary angioplasty with stenting significantly improve the capacity and effectiveness of the treatment of coronary ...
S. I. Vintizenko+3 more
doaj +1 more source
Clinical Trials With Pragmatic Elements: A Review of Use Cases and Real‐World Data Utilization
Clinical trials with pragmatic elements can capture diverse patient populations, enable efficient follow‐up, and reflect routine clinical practices; yet there is limited understanding of their design features, characteristics, and use of real‐world data (RWD). Based on a targeted search of PubMed/EMBASE (Jan‐2016 to Jul‐2024), a review was conducted to
Le Su+6 more
wiley +1 more source
Restenosis and progression of coronary atherosclerosis after coronary angioplasty
The relation between restenosis and progression of atherosclerosis in other coronary segments after angioplasty was studied in 98 consecutive patients with 110 coronary stenoses successfully treated with angioplasty. At early angiographic restudy (5 +/- 2 months after angioplasty) 37 patients (38%) had restenosis (defined as a stenosis greater than or ...
Angel Cequier+7 more
openaire +3 more sources